Akebia Therapeutics Inc.. (AKBA) NASDAQ
$1.13 (0.05) (-4.24%)
Market Cap: $212.79M
As of 09/25/23 04:00 PM EDT. Market closed.
Akebia Therapeutics Inc.. (AKBA)
NASDAQ
$1.13
(0.05) (-4.24%)
Market Cap: $212.79M
As of 09/25/23 04:00 PM EDT. Market closed.
akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both ... read more
akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. akebia’s global phase 3 program for vadadustat, which includes the pro2tect studies for non-dialysis patients with anemia associated with chronic kidney disease and the inno2vate studies for dialysis-dependent patients, is currently ongoing. for more information, please visit our website at www.akebia.com. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Butler
Full Time Employees
353
CEO Compensation (Base)
$594,720
CEO Compensation (Total)
$3.47M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Butler
Full Time Employees
353
CEO Compensation (Base)
$594,720
CEO Compensation (Total)
$3.47M
URL
Address
245 1st St, Massachusetts, Cambridge, 02142-1200.
PRICE CHART FOR AKEBIA THERAPEUTICS INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$1.18
Days Range
$1.10 - $1.17
52 week range
$0.24 - $1.84
Volume
7,097
Avg. Volume (30 days)
1,461,643
Market Cap
$212.79M
Dividend Yield
-
P/E
-
Shares Outstanding
188,313,807
Open
-
Previous Close
$1.18
Days Range
$1.10 - $1.17
52 week range
$0.24 - $1.84
Volume
7,097
Avg. Volume (30 days)
1,461,643
Market Cap
$212.79M
Dividend Yield
-
P/E
-
Shares Outstanding
188,313,807
FINANCIAL STATEMENTS FOR AKEBIA THERAPEUTICS INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AKEBIA THERAPEUTICS INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Hadas Nicole R. | SVP, Chief Legal Officer | May 25, 2023 | Sale | $1.22 | 63,186 | 77,270 | 524,344 | May 25, 2023, 09:01 PM |
| Dahan Michel | SVP, Chief Operating Officer | May 25, 2023 | Sale | $1.22 | 95,478 | 116,760 | 574,037 | May 25, 2023, 09:01 PM |
| Burke Steven Keith | SVP, Chief Medical Officer | May 16, 2023 | Sale | $1.07 | 63,567 | 67,890 | 530,487 | May 18, 2023, 06:20 PM |
| Spellman David A | SVP, CFO and Treasurer | May 16, 2023 | Sale | $1.07 | 63,567 | 67,890 | 446,483 | May 18, 2023, 06:19 PM |
| Butler John P. | CEO and President | Mar 01, 2023 | Sale | $0.88 | 91,868 | 80,614 | 1,622,481 | Mar 03, 2023, 08:01 AM |
| Hadas Nicole R. | SVP, Chief Legal Officer | Mar 01, 2023 | Sale | $0.88 | 13,034 | 11,437 | 295,231 | Mar 03, 2023, 08:01 AM |
| Burke Steven Keith | SVP, Chief Medical Officer | Mar 01, 2023 | Sale | $0.88 | 14,123 | 12,393 | 601,564 | Mar 03, 2023, 08:01 AM |
| Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2023 | Sale | $0.88 | 20,412 | 17,912 | 281,869 | Mar 03, 2023, 08:01 AM |
| Spellman David A | SVP, CFO and Treasurer | Mar 01, 2023 | Sale | $0.88 | 7,210 | 6,327 | 510,860 | Mar 03, 2023, 08:00 AM |
| Butler John P. | CEO and President | Feb 27, 2023 | Sale | $0.81 | 38,632 | 31,416 | 1,660,740 | Mar 01, 2023, 04:07 PM |
| Burke Steven Keith | SVP, Chief Medical Officer | Feb 27, 2023 | Sale | $0.81 | 7,539 | 6,131 | 608,177 | Mar 01, 2023, 04:06 PM |
| Spellman David A | SVP, CFO and Treasurer | Feb 27, 2023 | Sale | $0.81 | 7,539 | 6,131 | 517,260 | Mar 01, 2023, 04:05 PM |
| Burke Steven Keith | SVP, Chief Medical Officer | Aug 31, 2022 | Sale | $0.36 | 1,147 | 416 | 418,016 | Sep 01, 2022, 04:15 PM |
| GILMAN STEVEN C | Director | Jun 03, 2022 | Sale | $0.36 | 4,567 | 1,653 | 43,430 | Jun 07, 2022, 04:03 PM |
| Butler John P. | CEO and President | Mar 01, 2022 | Sale | $2.17 | 53,973 | 117,159 | 1,432,409 | Mar 02, 2022, 09:25 PM |
| Butler John P. | CEO and President | Feb 28, 2022 | Sale | $2.15 | 25,053 | 53,984 | 1,164,095 | Mar 02, 2022, 09:25 PM |
| Burke Steven Keith | SVP, Chief Medical Officer | Mar 01, 2022 | Sale | $2.17 | 7,656 | 16,619 | 217,663 | Mar 02, 2022, 09:12 PM |
| Burke Steven Keith | SVP, Chief Medical Officer | Feb 28, 2022 | Sale | $2.15 | 7,400 | 15,946 | 163,819 | Mar 02, 2022, 09:12 PM |
| Cotreau Violetta | SVP, Chief Accounting Officer | Feb 28, 2022 | Sale | $2.15 | 3,946 | 8,503 | 29,121 | Mar 02, 2022, 09:12 PM |
| Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2022 | Sale | $2.17 | 14,978 | 32,513 | 302,122 | Mar 02, 2022, 09:11 PM |
| Dahan Michel | SVP, Chief Operating Officer | Feb 28, 2022 | Sale | $2.15 | 6,555 | 14,125 | 258,995 | Mar 02, 2022, 09:11 PM |
| Faulkingham Dell | SVP, CCO | Mar 01, 2022 | Sale | $2.17 | 6,705 | 14,555 | 174,798 | Mar 02, 2022, 09:10 PM |
| Faulkingham Dell | SVP, CCO | Feb 28, 2022 | Sale | $2.15 | 6,479 | 13,961 | 130,546 | Mar 02, 2022, 09:10 PM |
| Hadas Nicole R. | SVP, Chief Legal Officer | Feb 28, 2022 | Sale | $2.15 | 6,555 | 14,125 | 265,748 | Mar 02, 2022, 09:10 PM |
| Hadas Nicole R. | SVP, Chief Legal Officer | Mar 01, 2022 | Sale | $2.17 | 14,507 | 31,490 | 308,875 | Mar 02, 2022, 09:10 PM |
| Spellman David A | SVP, CFO and Treasurer | Mar 01, 2022 | Sale | $2.17 | 803 | 1,743 | 128,599 | Mar 02, 2022, 09:09 PM |
| Spellman David A | SVP, CFO and Treasurer | Feb 28, 2022 | Sale | $2.15 | 7,400 | 15,946 | 69,402 | Mar 02, 2022, 09:09 PM |
| Cotreau Violetta | SVP, Chief Accounting Officer | Jan 03, 2022 | Sale | $2.29 | 5,833 | 13,335 | 33,067 | Jan 05, 2022, 04:11 PM |
| Burke Steven Keith | SVP, Chief Medical Officer | Aug 31, 2021 | Sale | $2.83 | 1,042 | 2,949 | 171,219 | Sep 02, 2021, 04:07 PM |
| Faulkingham Dell | SVP, CCO | Apr 01, 2021 | Sale | $3.40 | 952 | 3,237 | 137,025 | Apr 01, 2021, 08:35 PM |
| Spellman David A | SVP, CFO and Treasurer | Apr 01, 2021 | Sale | $3.40 | 790 | 2,686 | 76,802 | Apr 01, 2021, 08:34 PM |
| Hadas Nicole R. | SVP, Chief Legal Officer | Apr 01, 2021 | Sale | $3.40 | 1,060 | 3,604 | 272,303 | Apr 01, 2021, 08:33 PM |
| Dahan Michel | SVP, Chief Operating Officer | Apr 01, 2021 | Sale | $3.40 | 1,211 | 4,117 | 265,550 | Apr 01, 2021, 08:33 PM |
| Butler John P. | CEO and President | Apr 01, 2021 | Sale | $3.40 | 4,109 | 13,971 | 1,152,153 | Apr 01, 2021, 08:32 PM |
| Burke Steven Keith | SVP, Chief Medical Officer | Apr 01, 2021 | Sale | $3.40 | 1,081 | 3,675 | 170,761 | Apr 01, 2021, 08:31 PM |
| Butler John P. | CEO and President | Mar 01, 2021 | Sale | $3.40 | 49,990 | 169,771 | 1,141,416 | Mar 02, 2021, 04:10 PM |
| Faulkingham Dell | CCO | Mar 01, 2021 | Sale | $3.40 | 6,749 | 22,920 | 128,825 | Mar 02, 2021, 04:08 PM |
| Hadas Nicole R. | SVP, Chief Legal Officer | Mar 01, 2021 | Sale | $3.40 | 14,285 | 48,513 | 271,147 | Mar 02, 2021, 04:08 PM |
| Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2021 | Sale | $3.40 | 14,547 | 49,403 | 263,058 | Mar 02, 2021, 04:08 PM |
| Burke Steven Keith | SVP, Chief Medical Officer | Mar 01, 2021 | Sale | $3.40 | 7,558 | 25,668 | 161,442 | Mar 02, 2021, 04:06 PM |
| Smith Cynthia | Director | Jun 08, 2020 | Sale | $12.10 | 4,567 | 55,261 | 37,833 | Jun 09, 2020, 04:17 PM |
| GILMAN STEVEN C | Director | Jun 08, 2020 | Sale | $12.08 | 4,567 | 55,169 | 38,864 | Jun 09, 2020, 04:17 PM |
| GOWEN MAXINE | Director | Jun 08, 2020 | Sale | $12.05 | 4,567 | 55,032 | 24,133 | Jun 09, 2020, 04:17 PM |
| Faulkingham Dell | CCO | Jun 01, 2020 | Sale | $11.58 | 6,426 | 74,413 | 73,574 | Jun 02, 2020, 04:34 PM |
| Dahan Michel | SVP, Chief Operating Officer | Feb 28, 2020 | Sale | $8.70 | 6,972 | 60,656 | 204,960 | Mar 02, 2020, 07:29 PM |
| Hadas Nicole R. | SVP, Chief Legal Officer | Feb 28, 2020 | Sale | $8.70 | 7,050 | 61,335 | 212,756 | Mar 02, 2020, 07:28 PM |
| Amello Jason | SVP, CFO & Treasurer | Feb 28, 2020 | Sale | $8.70 | 6,976 | 60,691 | 144,642 | Mar 02, 2020, 07:27 PM |
| Tubridy Karen L | SVP, Chief Development Officer | Feb 28, 2020 | Sale | $8.70 | 3,454 | 30,050 | 84,679 | Mar 02, 2020, 07:26 PM |
| GILMAN STEVEN C | Director | Nov 20, 2019 | Buy | $3.43 | 5,800 | 19,894 | 29,731 | Nov 22, 2019, 06:20 AM |
| Smith Cynthia | Director | Nov 20, 2019 | Buy | $3.52 | 15,000 | 52,800 | 28,700 | Nov 22, 2019, 06:20 AM |
| Burke Steven Keith | SVP, Chief Medical Officer | Nov 20, 2019 | Buy | $3.58 | 27,000 | 96,660 | 37,000 | Nov 22, 2019, 06:19 AM |
| Butler John P. | CEO and President | Nov 20, 2019 | Buy | $3.44 | 50,000 | 172,000 | 887,732 | Nov 21, 2019, 06:32 AM |
| ADAMS ADRIAN | Director | Nov 20, 2019 | Buy | $3.41 | 50,000 | 170,500 | 63,700 | Nov 21, 2019, 06:31 AM |
| Butler John P. | CEO and President | Jun 03, 2019 | Option Exercise | $0.47 | 287,000 | 134,890 | 836,232 | Jun 05, 2019, 04:05 PM |
| Jain Rita | SVP, Chief Medical Officer | Apr 11, 2019 | Option Exercise | $7.70 | 4,409 | 33,949 | 96,332 | Apr 12, 2019, 04:01 PM |
| Dahan Michel | SVP, Chief Business Officer | Apr 11, 2019 | Option Exercise | $7.70 | 11,909 | 91,699 | 146,932 | Apr 12, 2019, 04:01 PM |
| Hadas Nicole R. | SVP, CLO & Secretary | Apr 11, 2019 | Option Exercise | $7.70 | 11,929 | 91,853 | 154,806 | Apr 12, 2019, 04:00 PM |
| Tubridy Karen L | SVP, Chief Development Officer | Apr 11, 2019 | Option Exercise | $7.70 | 6,075 | 46,777 | 55,324 | Apr 12, 2019, 04:00 PM |
| Amello Jason | SVP, CFO & Treasurer | Apr 11, 2019 | Option Exercise | $7.70 | 13,148 | 101,240 | 118,618 | Apr 12, 2019, 04:00 PM |
| Tubridy Karen L | SVP, Chief Development Officer | Dec 12, 2018 | Option Exercise | $8.94 | 11,928 | 106,636 | 30,229 | Dec 13, 2018, 08:18 AM |
| Jain Rita | SVP, Chief Medical Officer | Dec 12, 2018 | Option Exercise | $8.94 | 8,659 | 77,411 | 20,741 | Dec 13, 2018, 08:17 AM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Dec 12, 2018 | Option Exercise | $8.94 | 20,175 | 180,364 | 101,284 | Dec 13, 2018, 08:15 AM |
| Dahan Michel | SVP, Chief Business Officer | Dec 12, 2018 | Option Exercise | $8.94 | 23,385 | 209,062 | 93,841 | Dec 13, 2018, 08:14 AM |
| Butler John P. | CEO & President | Dec 12, 2018 | Option Exercise | $8.94 | 135,697 | 1,213,131 | 374,617 | Dec 13, 2018, 08:10 AM |
| Amello Jason | SVP, CFO & Treasurer | Dec 12, 2018 | Option Exercise | $8.94 | 22,235 | 198,781 | 66,501 | Dec 13, 2018, 08:08 AM |
| Butler John P. | CEO and President | Jul 11, 2018 | Option Exercise | $0.47 | 100,000 | 47,000 | 510,314 | Jul 12, 2018, 04:59 PM |
| Nash Duane | Director | Feb 15, 2018 | Sale | $14.62 | 1,000 | 14,620 | 21,499 | Feb 16, 2018, 04:07 PM |
| Nash Duane | Director | Oct 02, 2017 | Sale | $19.64 | 1,188 | 23,332 | 22,499 | Oct 04, 2017, 04:21 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Oct 02, 2017 | Sale | $19.89 | 7,803 | 155,188 | 108,054 | Oct 04, 2017, 04:21 PM |
| Dahan Michel | SVP, Chief Business Officer | Oct 02, 2017 | Sale | $19.64 | 1,398 | 27,457 | 95,826 | Oct 04, 2017, 04:20 PM |
| Dahan Michel | SVP, Chief Business Officer | Sep 28, 2017 | Sale | $19.30 | 5,000 | 96,500 | 97,224 | Oct 02, 2017, 04:04 PM |
| Dahan Michel | SVP, Chief Business Officer | Aug 15, 2017 | Sale | $15.00 | 5,000 | 75,000 | 102,224 | Aug 17, 2017, 04:06 PM |
| Satter Muneer A | Director | Jul 05, 2017 | Buy | $14.50 | 1,034,482 | 14,999,989 | 3,037,042 | Jul 11, 2017, 04:14 PM |
| Dahan Michel | SVP, Chief Business Officer | Jul 03, 2017 | Sale | $14.26 | 1,399 | 19,947 | 107,224 | Jul 06, 2017, 12:25 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Jul 03, 2017 | Sale | $14.26 | 1,554 | 22,156 | 109,607 | Jul 06, 2017, 12:24 PM |
| Nash Duane | Director | Jul 03, 2017 | Sale | $14.27 | 990 | 14,127 | 23,687 | Jul 06, 2017, 12:23 PM |
| Dahan Michel | SVP, Chief Business Officer | Apr 03, 2017 | Sale | $9.18 | 1,401 | 12,858 | 108,623 | Apr 04, 2017, 04:01 PM |
| Nash Duane | Director | Apr 03, 2017 | Sale | $9.20 | 991 | 9,119 | 24,677 | Apr 04, 2017, 04:01 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Apr 03, 2017 | Sale | $9.18 | 1,556 | 14,280 | 109,856 | Apr 04, 2017, 04:01 PM |
| Butler John P. | CEO and President | Jan 19, 2017 | Option Exercise | $0.47 | 20,000 | 9,400 | 373,480 | Jan 23, 2017, 04:10 PM |
| Dahan Michel | SVP, Chief Business Officer | Jan 01, 2017 | Sale | $10.49 | 1,629 | 17,089 | 70,524 | Jan 03, 2017, 04:02 PM |
| Nash Duane | Director | Jan 03, 2017 | Sale | $10.46 | 1,980 | 20,711 | 25,668 | Jan 03, 2017, 04:02 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Jan 01, 2017 | Sale | $10.49 | 1,810 | 18,988 | 82,912 | Jan 03, 2017, 04:01 PM |
| Nash Duane | Director | Oct 03, 2016 | Sale | $8.96 | 1,981 | 17,746 | 27,648 | Oct 04, 2016, 04:12 PM |
| Dahan Michel | SVP, Chief Business Officer | Oct 01, 2016 | Sale | $8.95 | 1,401 | 12,546 | 72,153 | Oct 04, 2016, 04:12 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Oct 01, 2016 | Sale | $8.95 | 1,556 | 13,934 | 83,915 | Oct 04, 2016, 04:12 PM |
| Nash Duane | Director | Jul 06, 2016 | Sale | $7.48 | 1,980 | 14,819 | 29,629 | Jul 07, 2016, 04:07 PM |
| Dahan Michel | SVP, Chief Business Officer | Jul 05, 2016 | Sale | $7.47 | 1,402 | 10,468 | 73,554 | Jul 06, 2016, 04:08 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Jul 05, 2016 | Sale | $7.47 | 1,557 | 11,625 | 85,471 | Jul 06, 2016, 04:08 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Apr 04, 2016 | Sale | $9.41 | 1,556 | 14,642 | 85,528 | Apr 05, 2016, 04:03 PM |
| Dahan Michel | SVP, Chief Business Officer | Apr 04, 2016 | Sale | $9.41 | 1,401 | 13,183 | 74,956 | Apr 05, 2016, 04:01 PM |
| Butler John P. | CEO and President | Jan 15, 2016 | Option Exercise | $0.47 | 25,000 | 11,750 | 225,673 | Jan 19, 2016, 04:00 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Jan 04, 2016 | Sale | $12.28 | 1,811 | 22,239 | 64,584 | Jan 06, 2016, 04:04 PM |
| Nash Duane | Director | Oct 02, 2015 | Sale | $8.65 | 996 | 8,617 | 31,609 | Oct 05, 2015, 04:06 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Oct 02, 2015 | Sale | $8.67 | 1,484 | 12,860 | 65,260 | Oct 05, 2015, 04:02 PM |
| Nash Duane | Director | Jul 02, 2015 | Sale | $9.53 | 996 | 9,490 | 32,605 | Jul 06, 2015, 04:04 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Jul 02, 2015 | Sale | $9.54 | 1,484 | 14,160 | 66,744 | Jul 06, 2015, 04:03 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Apr 02, 2015 | Sale | $9.09 | 1,483 | 13,478 | 67,015 | Jul 02, 2015, 07:29 AM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Jan 02, 2015 | Sale | $11.46 | 1,715 | 19,655 | 68,498 | Jul 02, 2015, 07:27 AM |
| Nash Duane | Director | Apr 01, 2015 | Option Exercise | $9.51 | 1,980 | 18,830 | 13,012 | Jun 09, 2015, 04:19 PM |
| Nash Duane | Director | Apr 02, 2015 | Sale | $9.09 | 996 | 9,052 | 12,016 | Jun 09, 2015, 04:19 PM |
| Nash Duane | Director | Jan 01, 2015 | Option Exercise | $11.64 | 1,980 | 23,047 | 13,809 | Jun 09, 2015, 04:13 PM |
| Nash Duane | Director | Jan 02, 2015 | Sale | $11.46 | 995 | 11,403 | 12,814 | Jun 09, 2015, 04:13 PM |
| Nash Duane | Director | Dec 23, 2014 | Option Exercise | $11.54 | 23,762 | 274,213 | 23,762 | Jun 09, 2015, 04:07 PM |
| Nash Duane | Director | Dec 26, 2014 | Sale | $11.19 | 5,169 | 57,846 | 11,829 | Jun 09, 2015, 04:07 PM |
| Nash Duane | Director | Dec 24, 2014 | Sale | $11.26 | 6,764 | 76,189 | 16,998 | Jun 09, 2015, 04:07 PM |
| Butler John P. | CEO and President | May 26, 2015 | Option Exercise | $0.47 | 50,000 | 23,500 | 198,350 | May 28, 2015, 06:31 AM |
| Satter Muneer A | Director | Apr 22, 2015 | Buy | $8.25 | 420,000 | 3,465,000 | 2,002,560 | Apr 22, 2015, 04:25 PM |
| Nash Duane | Director | Apr 01, 2015 | Option Exercise | $9.51 | 1,980 | 18,830 | 13,012 | Apr 06, 2015, 04:14 PM |
| Nash Duane | Director | Apr 02, 2015 | Sale | $9.09 | 996 | 9,052 | 12,016 | Apr 06, 2015, 04:14 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Apr 01, 2015 | Option Exercise | $9.51 | 4,539 | 43,166 | 77,576 | Apr 06, 2015, 04:13 PM |
| Hadas Nicole R. | SVP, General Counsel, Sec. | Apr 02, 2015 | Sale | $9.09 | 1,483 | 13,478 | 76,093 | Apr 06, 2015, 04:13 PM |
| Butler John P. | CEO and President | Mar 09, 2015 | Option Exercise | $0.47 | 100,000 | 47,000 | 148,350 | Mar 11, 2015, 06:23 AM |
| Hadas Nicole R. | VP General Counsel & Secretary | Jan 01, 2015 | Option Exercise | $11.64 | 4,539 | 52,834 | 74,752 | Jan 05, 2015, 04:35 PM |
| Hadas Nicole R. | VP General Counsel & Secretary | Jan 02, 2015 | Sale | $11.46 | 1,715 | 19,655 | 73,037 | Jan 05, 2015, 04:35 PM |
| Nash Duane | Director | Jan 01, 2015 | Option Exercise | $11.64 | 1,980 | 23,047 | 13,809 | Jan 05, 2015, 04:32 PM |
| Nash Duane | Director | Jan 02, 2015 | Sale | $11.46 | 995 | 11,403 | 12,814 | Jan 05, 2015, 04:32 PM |
| Nash Duane | Director | Dec 23, 2014 | Option Exercise | $11.54 | 23,762 | 274,213 | 23,762 | Jan 05, 2015, 04:30 PM |
| Nash Duane | Director | Dec 26, 2014 | Sale | $11.19 | 5,169 | 57,846 | 11,829 | Jan 05, 2015, 04:30 PM |
| Nash Duane | Director | Dec 24, 2014 | Sale | $11.26 | 6,764 | 76,189 | 16,998 | Jan 05, 2015, 04:30 PM |
| Butler John P. | CEO and President | Dec 29, 2014 | Buy | $11.57 | 1,000 | 11,567 | 48,350 | Dec 29, 2014, 05:16 PM |
| Nash Duane | Director | Dec 23, 2014 | Option Exercise | $11.54 | 23,762 | 274,213 | 23,762 | Dec 29, 2014, 04:25 PM |
| Nash Duane | Director | Dec 26, 2014 | Sale | $11.19 | 5,169 | 57,846 | 11,829 | Dec 29, 2014, 04:25 PM |
| Nash Duane | Director | Dec 24, 2014 | Sale | $11.26 | 6,764 | 76,189 | 16,998 | Dec 29, 2014, 04:25 PM |
| Butler John P. | CEO and President | Dec 22, 2014 | Buy | $11.92 | 1,000 | 11,916 | 47,350 | Dec 22, 2014, 04:11 PM |
| Butler John P. | CEO and President | Dec 15, 2014 | Buy | $11.34 | 1,000 | 11,336 | 46,350 | Dec 18, 2014, 04:02 PM |
| Hadas Nicole R. | VP General Counsel & Secretary | Dec 02, 2014 | Option Exercise | $11.43 | 5,910 | 67,551 | 70,213 | Dec 03, 2014, 04:07 PM |
| Renaud Ronald C JR | Director | Dec 02, 2014 | Buy | $11.92 | 5,000 | 59,587 | 5,000 | Dec 02, 2014, 06:42 PM |
| Amello Jason | SVP, CFO & Treasurer | Nov 26, 2014 | Buy | $13.22 | 1,000 | 13,220 | 5,000 | Dec 01, 2014, 06:13 AM |
| Satter Muneer A | Director | Nov 25, 2014 | Buy | $13.18 | 5,000 | 65,900 | 1,582,560 | Nov 26, 2014, 07:26 AM |
| Satter Muneer A | Director | Nov 24, 2014 | Buy | $13.88 | 5,000 | 69,400 | 1,577,560 | Nov 25, 2014, 06:02 AM |
| Satter Muneer A | Director | Nov 21, 2014 | Buy | $14.73 | 5,000 | 73,650 | 1,572,560 | Nov 24, 2014, 06:50 AM |
| Satter Muneer A | Director | Nov 20, 2014 | Buy | $14.70 | 5,000 | 73,500 | 1,567,560 | Nov 21, 2014, 07:40 AM |
| Satter Muneer A | Director | Nov 19, 2014 | Buy | $14.85 | 5,000 | 74,250 | 1,562,560 | Nov 20, 2014, 06:13 AM |
| Satter Muneer A | Director | Nov 18, 2014 | Buy | $13.84 | 5,000 | 69,200 | 1,557,560 | Nov 19, 2014, 06:04 AM |
| Satter Muneer A | Director | Nov 17, 2014 | Buy | $12.94 | 5,000 | 64,700 | 1,552,560 | Nov 18, 2014, 07:18 AM |
| Satter Muneer A | Director | Nov 13, 2014 | Buy | $11.56 | 5,000 | 57,800 | 1,542,560 | Nov 14, 2014, 07:31 AM |
| GOWEN MAXINE | Director | Nov 13, 2014 | Buy | $11.82 | 1,300 | 15,365 | 1,300 | Nov 14, 2014, 06:55 AM |
| Butler John P. | CEO and President | Nov 11, 2014 | Option Exercise | $0.47 | 30,500 | 14,335 | 44,350 | Nov 13, 2014, 06:21 AM |
| Butler John P. | CEO and President | Nov 12, 2014 | Buy | $10.31 | 1,000 | 10,305 | 45,350 | Nov 13, 2014, 06:21 AM |
| Satter Muneer A | Director | Nov 12, 2014 | Buy | $11.90 | 5,000 | 59,515 | 1,537,560 | Nov 13, 2014, 06:20 AM |
| Novartis Bioventures Ltd | 10% Owner | Mar 25, 2014 | Buy | $17.00 | 182,590 | 3,104,030 | 182,590 | Mar 27, 2014, 04:02 PM |
| WYZGA MICHAEL S | Director | Mar 25, 2014 | Buy | $17.00 | 1,500 | 25,500 | 1,500 | Mar 27, 2014, 04:01 PM |
| Hadas Nicole R. | See Remarks | Mar 25, 2014 | Buy | $17.00 | 3,500 | 59,500 | 76,123 | Mar 27, 2014, 04:00 PM |
| Satter Muneer A | Director | Mar 25, 2014 | Buy | $17.00 | 91,295 | 1,552,015 | 1,532,560 | Mar 27, 2014, 04:00 PM |
| Butler John P. | President and CEO | Mar 25, 2014 | Buy | $17.00 | 13,850 | 235,450 | 13,850 | Mar 27, 2014, 04:00 PM |
| Amello Jason | SVP, CFO & Treasurer | Mar 25, 2014 | Buy | $17.00 | 4,000 | 68,000 | 4,000 | Mar 27, 2014, 04:00 PM |
| Novo A/S | 10% Owner | Mar 25, 2014 | Buy | $17.00 | 182,590 | 3,104,030 | 1,516,387 | Mar 26, 2014, 05:44 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Hadas Nicole R. | SVP, Chief Legal Officer | 05/25/2023 | 77,270 |
| Dahan Michel | SVP, Chief Operating Officer | 05/25/2023 | 116,760 |
| Burke Steven Keith | SVP, Chief Medical Officer | 05/16/2023 | 67,890 |
| Spellman David A | SVP, CFO and Treasurer | 05/16/2023 | 67,890 |
| Butler John P. | CEO and President | 03/01/2023 | 80,614 |
| Hadas Nicole R. | SVP, Chief Legal Officer | 03/01/2023 | 11,437 |
| Burke Steven Keith | SVP, Chief Medical Officer | 03/01/2023 | 12,393 |
| Dahan Michel | SVP, Chief Operating Officer | 03/01/2023 | 17,912 |
| Spellman David A | SVP, CFO and Treasurer | 03/01/2023 | 6,327 |
| Butler John P. | CEO and President | 02/27/2023 | 31,416 |
| Burke Steven Keith | SVP, Chief Medical Officer | 02/27/2023 | 6,131 |
| Spellman David A | SVP, CFO and Treasurer | 02/27/2023 | 6,131 |
| Burke Steven Keith | SVP, Chief Medical Officer | 08/31/2022 | 416 |
| GILMAN STEVEN C | Director | 06/03/2022 | 1,653 |
| Butler John P. | CEO and President | 03/01/2022 | 117,159 |
| Butler John P. | CEO and President | 02/28/2022 | 53,984 |
| Burke Steven Keith | SVP, Chief Medical Officer | 03/01/2022 | 16,619 |
| Burke Steven Keith | SVP, Chief Medical Officer | 02/28/2022 | 15,946 |
| Cotreau Violetta | SVP, Chief Accounting Officer | 02/28/2022 | 8,503 |
| Dahan Michel | SVP, Chief Operating Officer | 03/01/2022 | 32,513 |
| Dahan Michel | SVP, Chief Operating Officer | 02/28/2022 | 14,125 |
| Faulkingham Dell | SVP, CCO | 03/01/2022 | 14,555 |
| Faulkingham Dell | SVP, CCO | 02/28/2022 | 13,961 |
| Hadas Nicole R. | SVP, Chief Legal Officer | 02/28/2022 | 14,125 |
| Hadas Nicole R. | SVP, Chief Legal Officer | 03/01/2022 | 31,490 |
| Spellman David A | SVP, CFO and Treasurer | 03/01/2022 | 1,743 |
| Spellman David A | SVP, CFO and Treasurer | 02/28/2022 | 15,946 |
| Cotreau Violetta | SVP, Chief Accounting Officer | 01/03/2022 | 13,335 |
| Burke Steven Keith | SVP, Chief Medical Officer | 08/31/2021 | 2,949 |
| Faulkingham Dell | SVP, CCO | 04/01/2021 | 3,237 |
| Spellman David A | SVP, CFO and Treasurer | 04/01/2021 | 2,686 |
| Hadas Nicole R. | SVP, Chief Legal Officer | 04/01/2021 | 3,604 |
| Dahan Michel | SVP, Chief Operating Officer | 04/01/2021 | 4,117 |
| Butler John P. | CEO and President | 04/01/2021 | 13,971 |
| Burke Steven Keith | SVP, Chief Medical Officer | 04/01/2021 | 3,675 |
| Butler John P. | CEO and President | 03/01/2021 | 169,771 |
| Faulkingham Dell | CCO | 03/01/2021 | 22,920 |
| Hadas Nicole R. | SVP, Chief Legal Officer | 03/01/2021 | 48,513 |
| Dahan Michel | SVP, Chief Operating Officer | 03/01/2021 | 49,403 |
| Burke Steven Keith | SVP, Chief Medical Officer | 03/01/2021 | 25,668 |
| Smith Cynthia | Director | 06/08/2020 | 55,261 |
| GILMAN STEVEN C | Director | 06/08/2020 | 55,169 |
| GOWEN MAXINE | Director | 06/08/2020 | 55,032 |
| Faulkingham Dell | CCO | 06/01/2020 | 74,413 |
| Dahan Michel | SVP, Chief Operating Officer | 02/28/2020 | 60,656 |
| Hadas Nicole R. | SVP, Chief Legal Officer | 02/28/2020 | 61,335 |
| Amello Jason | SVP, CFO & Treasurer | 02/28/2020 | 60,691 |
| Tubridy Karen L | SVP, Chief Development Officer | 02/28/2020 | 30,050 |
| GILMAN STEVEN C | Director | 11/20/2019 | 19,894 |
| Smith Cynthia | Director | 11/20/2019 | 52,800 |
| Burke Steven Keith | SVP, Chief Medical Officer | 11/20/2019 | 96,660 |
| Butler John P. | CEO and President | 11/20/2019 | 172,000 |
| ADAMS ADRIAN | Director | 11/20/2019 | 170,500 |
| Butler John P. | CEO and President | 06/03/2019 | 134,890 |
| Jain Rita | SVP, Chief Medical Officer | 04/11/2019 | 33,949 |
| Dahan Michel | SVP, Chief Business Officer | 04/11/2019 | 91,699 |
| Hadas Nicole R. | SVP, CLO & Secretary | 04/11/2019 | 91,853 |
| Tubridy Karen L | SVP, Chief Development Officer | 04/11/2019 | 46,777 |
| Amello Jason | SVP, CFO & Treasurer | 04/11/2019 | 101,240 |
| Tubridy Karen L | SVP, Chief Development Officer | 12/12/2018 | 106,636 |
| Jain Rita | SVP, Chief Medical Officer | 12/12/2018 | 77,411 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 12/12/2018 | 180,364 |
| Dahan Michel | SVP, Chief Business Officer | 12/12/2018 | 209,062 |
| Butler John P. | CEO & President | 12/12/2018 | 1,213,131 |
| Amello Jason | SVP, CFO & Treasurer | 12/12/2018 | 198,781 |
| Butler John P. | CEO and President | 07/11/2018 | 47,000 |
| Nash Duane | Director | 02/15/2018 | 14,620 |
| Nash Duane | Director | 10/02/2017 | 23,332 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 10/02/2017 | 155,188 |
| Dahan Michel | SVP, Chief Business Officer | 10/02/2017 | 27,457 |
| Dahan Michel | SVP, Chief Business Officer | 09/28/2017 | 96,500 |
| Dahan Michel | SVP, Chief Business Officer | 08/15/2017 | 75,000 |
| Satter Muneer A | Director | 07/05/2017 | 14,999,989 |
| Dahan Michel | SVP, Chief Business Officer | 07/03/2017 | 19,947 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 07/03/2017 | 22,156 |
| Nash Duane | Director | 07/03/2017 | 14,127 |
| Dahan Michel | SVP, Chief Business Officer | 04/03/2017 | 12,858 |
| Nash Duane | Director | 04/03/2017 | 9,119 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 04/03/2017 | 14,280 |
| Butler John P. | CEO and President | 01/19/2017 | 9,400 |
| Dahan Michel | SVP, Chief Business Officer | 01/01/2017 | 17,089 |
| Nash Duane | Director | 01/03/2017 | 20,711 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 01/01/2017 | 18,988 |
| Nash Duane | Director | 10/03/2016 | 17,746 |
| Dahan Michel | SVP, Chief Business Officer | 10/01/2016 | 12,546 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 10/01/2016 | 13,934 |
| Nash Duane | Director | 07/06/2016 | 14,819 |
| Dahan Michel | SVP, Chief Business Officer | 07/05/2016 | 10,468 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 07/05/2016 | 11,625 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 04/04/2016 | 14,642 |
| Dahan Michel | SVP, Chief Business Officer | 04/04/2016 | 13,183 |
| Butler John P. | CEO and President | 01/15/2016 | 11,750 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 01/04/2016 | 22,239 |
| Nash Duane | Director | 10/02/2015 | 8,617 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 10/02/2015 | 12,860 |
| Nash Duane | Director | 07/02/2015 | 9,490 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 07/02/2015 | 14,160 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 04/02/2015 | 13,478 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 01/02/2015 | 19,655 |
| Nash Duane | Director | 04/01/2015 | 18,830 |
| Nash Duane | Director | 04/02/2015 | 9,052 |
| Nash Duane | Director | 01/01/2015 | 23,047 |
| Nash Duane | Director | 01/02/2015 | 11,403 |
| Nash Duane | Director | 12/23/2014 | 274,213 |
| Nash Duane | Director | 12/26/2014 | 57,846 |
| Nash Duane | Director | 12/24/2014 | 76,189 |
| Butler John P. | CEO and President | 05/26/2015 | 23,500 |
| Satter Muneer A | Director | 04/22/2015 | 3,465,000 |
| Nash Duane | Director | 04/01/2015 | 18,830 |
| Nash Duane | Director | 04/02/2015 | 9,052 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 04/01/2015 | 43,166 |
| Hadas Nicole R. | SVP, General Counsel, Sec. | 04/02/2015 | 13,478 |
| Butler John P. | CEO and President | 03/09/2015 | 47,000 |
| Hadas Nicole R. | VP General Counsel & Secretary | 01/01/2015 | 52,834 |
| Hadas Nicole R. | VP General Counsel & Secretary | 01/02/2015 | 19,655 |
| Nash Duane | Director | 01/01/2015 | 23,047 |
| Nash Duane | Director | 01/02/2015 | 11,403 |
| Nash Duane | Director | 12/23/2014 | 274,213 |
| Nash Duane | Director | 12/26/2014 | 57,846 |
| Nash Duane | Director | 12/24/2014 | 76,189 |
| Butler John P. | CEO and President | 12/29/2014 | 11,567 |
| Nash Duane | Director | 12/23/2014 | 274,213 |
| Nash Duane | Director | 12/26/2014 | 57,846 |
| Nash Duane | Director | 12/24/2014 | 76,189 |
| Butler John P. | CEO and President | 12/22/2014 | 11,916 |
| Butler John P. | CEO and President | 12/15/2014 | 11,336 |
| Hadas Nicole R. | VP General Counsel & Secretary | 12/02/2014 | 67,551 |
| Renaud Ronald C JR | Director | 12/02/2014 | 59,587 |
| Amello Jason | SVP, CFO & Treasurer | 11/26/2014 | 13,220 |
| Satter Muneer A | Director | 11/25/2014 | 65,900 |
| Satter Muneer A | Director | 11/24/2014 | 69,400 |
| Satter Muneer A | Director | 11/21/2014 | 73,650 |
| Satter Muneer A | Director | 11/20/2014 | 73,500 |
| Satter Muneer A | Director | 11/19/2014 | 74,250 |
| Satter Muneer A | Director | 11/18/2014 | 69,200 |
| Satter Muneer A | Director | 11/17/2014 | 64,700 |
| Satter Muneer A | Director | 11/13/2014 | 57,800 |
| GOWEN MAXINE | Director | 11/13/2014 | 15,365 |
| Butler John P. | CEO and President | 11/11/2014 | 14,335 |
| Butler John P. | CEO and President | 11/12/2014 | 10,305 |
| Satter Muneer A | Director | 11/12/2014 | 59,515 |
| Novartis Bioventures Ltd | 10% Owner | 03/25/2014 | 3,104,030 |
| WYZGA MICHAEL S | Director | 03/25/2014 | 25,500 |
| Hadas Nicole R. | See Remarks | 03/25/2014 | 59,500 |
| Satter Muneer A | Director | 03/25/2014 | 1,552,015 |
| Butler John P. | President and CEO | 03/25/2014 | 235,450 |
| Amello Jason | SVP, CFO & Treasurer | 03/25/2014 | 68,000 |
| Novo A/S | 10% Owner | 03/25/2014 | 3,104,030 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AKEBIA THERAPEUTICS INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 3,330,727 | 0.00439% | 42.43% | Other |
| BLACKROCK INC. | 2,736,856 | 0.00007% | 1.23% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,772,977 | 0.00019% | 5.38% | Other |
| TUDOR INVESTMENT CORP ET AL | 142,274 | 0.00155% | No change | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR AKEBIA THERAPEUTICS INC.
STOCK BUYBACKS FOR AKEBIA THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
1.11%
1Q
12/31/2022
1.53%
2Q
09/30/2022
1.60%
3Q
06/30/2022
-1.87%
4Q
03/31/2022
4.02%
5Q
12/31/2021
6.97%
6Q
09/30/2021
7.50%
7Q
06/30/2021
15.80%
8Q
03/31/2021
21.45%
9Q
12/31/2020
28.70%
10Q
09/30/2020
30.35%
11Q
06/30/2020
36.46%
12Q
03/31/2020
45.50%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AKEBIA THERAPEUTICS INC.
LOADING...